Literature DB >> 15814534

Chronic kidney disease as cause of cardiovascular morbidity and mortality.

R Vanholder1, Z Massy, A Argiles, G Spasovski, F Verbeke, N Lameire.   

Abstract

To make an evidence-based evaluation of the relationship between kidney failure and cardiovascular risk, we reviewed the literature obtained from a PubMed search using pre-defined keywords related to both conditions and covering 18 years (1986 until end 2003). Eighty-five publications, covering 552 258 subjects, are summarized. All but three studies support a link between kidney dysfunction and cardiovascular risk. More importantly, the association is observed very early during the evolution of renal failure: an accelerated cardiovascular risk appears at varying glomerular filtration rate (GFR) cut-off values, which were >/=60 ml/min in at least 20 studies. Many studies lacked a clear definition of cardiovascular disease and/or used a single determination of serum creatinine or GFR as an index of kidney function, which is not necessarily corresponding to well-defined chronic kidney disease. In six studies, however, chronic kidney dysfunction and cardiovascular disease were well defined and the results of these confirm the impact of kidney dysfunction. It is concluded that there is an undeniable link between kidney dysfunction and cardiovascular risk and that the presence of even subtle kidney dysfunction should be considered as one of the conditions necessitating intensive prevention of this cardiovascular risk.

Entities:  

Mesh:

Year:  2005        PMID: 15814534     DOI: 10.1093/ndt/gfh813

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  166 in total

Review 1.  Atherosclerosis in CKD: differences from the general population.

Authors:  Tilman B Drüeke; Ziad A Massy
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

Review 2.  PCSK9 in chronic kidney disease.

Authors:  P Pavlakou; E Liberopoulos; E Dounousi; M Elisaf
Journal:  Int Urol Nephrol       Date:  2017-01-13       Impact factor: 2.370

3.  Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease.

Authors:  Ashwini Pai; Elizabeth M Leaf; Mohga El-Abbadi; Cecilia M Giachelli
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  A randomized trial of dietary sodium restriction in CKD.

Authors:  Emma J McMahon; Judith D Bauer; Carmel M Hawley; Nicole M Isbel; Michael Stowasser; David W Johnson; Katrina L Campbell
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

Review 5.  Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University.

Authors:  Nikolaus Marx; Heidi Noels; Joachim Jankowski; Jürgen Floege; Danilo Fliser; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2018-05-04       Impact factor: 5.460

Review 6.  The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.

Authors:  Raymond Vanholder; Eva Schepers; Anneleen Pletinck; Evi V Nagler; Griet Glorieux
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

7.  Low serum testosterone increases mortality risk among male dialysis patients.

Authors:  Juan Jesús Carrero; Abdul Rashid Qureshi; Paolo Parini; Stefan Arver; Bengt Lindholm; Peter Bárány; Olof Heimbürger; Peter Stenvinkel
Journal:  J Am Soc Nephrol       Date:  2009-01-14       Impact factor: 10.121

8.  Chronic kidney disease is often unrecognized among patients with coronary heart disease: The REGARDS Cohort Study.

Authors:  William M McClellan; Britt B Newsome; Leslie A McClure; Mary Cushman; George Howard; Paul Audhya; Jerome L Abramson; David G Warnock
Journal:  Am J Nephrol       Date:  2008-07-26       Impact factor: 3.754

9.  Glomerular filtration rate: A prognostic marker in atrial fibrillation-A subanalysis of the AntiThrombotic Agents Atrial Fibrillation.

Authors:  Riccardo Proietti; Lucio Gonzini; Giovanni Pizzimenti; Antonietta Ledda; Pietro Sanna; Ahmed AlTurki; Vincenzo Russo; Mauro Lencioni
Journal:  Clin Cardiol       Date:  2018-12-04       Impact factor: 2.882

10.  Coronary calcification in patients with chronic kidney disease and coronary artery disease.

Authors:  Satoko Nakamura; Hatsue Ishibashi-Ueda; Sinichiro Niizuma; Fumiki Yoshihara; Takeshi Horio; Yuhei Kawano
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.